These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1251 related items for PubMed ID: 12927427

  • 1. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V, Million Women Study Collaborators.
    Lancet; 2003 Aug 09; 362(9382):419-27. PubMed ID: 12927427
    [Abstract] [Full Text] [Related]

  • 2. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V, Bull D, Reeves G, Million Women Study Collaborators.
    Lancet; 2003 Aug 09; 365(9470):1543-51. PubMed ID: 15866308
    [Abstract] [Full Text] [Related]

  • 3. Hormone replacement therapy and false positive recall in the Million Women Study: patterns of use, hormonal constituents and consistency of effect.
    Banks E, Reeves G, Beral V, Bull D, Crossley B, Simmonds M, Hilton E, Bailey S, Barrett N, Briers P, English R, Jackson A, Kutt E, Lavelle J, Rockall L, Wallis MG, Wilson M, Patnick J.
    Breast Cancer Res; 2006 Aug 09; 8(1):R8. PubMed ID: 16417651
    [Abstract] [Full Text] [Related]

  • 4. Use of HRT and the subsequent risk of cancer.
    Beral V, Banks E, Reeves G, Appleby P.
    J Epidemiol Biostat; 1999 Aug 09; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [Abstract] [Full Text] [Related]

  • 5. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 2019 Sep 28; 394(10204):1159-1168. PubMed ID: 31474332
    [Abstract] [Full Text] [Related]

  • 6. Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
    Reeves GK, Beral V, Green J, Gathani T, Bull D, Million Women Study Collaborators.
    Lancet Oncol; 2006 Nov 28; 7(11):910-8. PubMed ID: 17081916
    [Abstract] [Full Text] [Related]

  • 7. Evidence from randomised trials on the long-term effects of hormone replacement therapy.
    Beral V, Banks E, Reeves G.
    Lancet; 2002 Sep 21; 360(9337):942-4. PubMed ID: 12354487
    [Abstract] [Full Text] [Related]

  • 8. Ovarian cancer and hormone replacement therapy in the Million Women Study.
    Beral V, Million Women Study Collaborators, Bull D, Green J, Reeves G.
    Lancet; 2007 May 19; 369(9574):1703-10. PubMed ID: 17512855
    [Abstract] [Full Text] [Related]

  • 9. Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT).
    Sourander L, Rajala T, Räihä I, Mäkinen J, Erkkola R, Helenius H.
    Lancet; 2007 May 19; 352(9145):1965-9. PubMed ID: 9872245
    [Abstract] [Full Text] [Related]

  • 10. Hormone replacement therapy and the breast.
    Dixon JM.
    Surg Oncol; 2003 Dec 19; 12(4):251-63. PubMed ID: 14998565
    [Abstract] [Full Text] [Related]

  • 11. [Estrogen replacement therapy and breast cancer].
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Tidsskr Nor Laegeforen; 2005 Feb 03; 125(3):282-5. PubMed ID: 15702147
    [Abstract] [Full Text] [Related]

  • 12. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study.
    Benson VS, Pirie K, Green J, Bull D, Casabonne D, Reeves GK, Beral V, Million Women Study Collaborators.
    Int J Cancer; 2010 Oct 01; 127(7):1692-8. PubMed ID: 20091865
    [Abstract] [Full Text] [Related]

  • 13. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian Women and Cancer study.
    Bakken K, Alsaker E, Eggen AE, Lund E.
    Int J Cancer; 2004 Oct 20; 112(1):130-4. PubMed ID: 15305384
    [Abstract] [Full Text] [Related]

  • 14. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M, Sands RH, McLaren M, Kirk G, Darko D.
    Fam Pract; 2000 Dec 20; 17(6):497-507. PubMed ID: 11120722
    [Abstract] [Full Text] [Related]

  • 15. Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases.
    Vinogradova Y, Coupland C, Hippisley-Cox J.
    BMJ; 2020 Oct 28; 371():m3873. PubMed ID: 33115755
    [Abstract] [Full Text] [Related]

  • 16. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec 28; 15(6):453-65. PubMed ID: 11826770
    [Abstract] [Full Text] [Related]

  • 17. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.
    Sellers TA, Mink PJ, Cerhan JR, Zheng W, Anderson KE, Kushi LH, Folsom AR.
    Ann Intern Med; 1997 Dec 01; 127(11):973-80. PubMed ID: 9412302
    [Abstract] [Full Text] [Related]

  • 18. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE.
    Acta Endocrinol (Copenh); 1991 Dec 01; 125 Suppl 1():13-26. PubMed ID: 1801500
    [Abstract] [Full Text] [Related]

  • 19. Hormone replacement therapy and risk of breast cancer with a favorable histology: results of the Iowa Women's Health Study.
    Gapstur SM, Morrow M, Sellers TA.
    JAMA; 1999 Jun 09; 281(22):2091-7. PubMed ID: 10367819
    [Abstract] [Full Text] [Related]

  • 20. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
    Lancet; 1997 Oct 11; 350(9084):1047-59. PubMed ID: 10213546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 63.